Treatment of Mastitis
Immediate Treatment Approach
For lactational mastitis, begin with a 1-2 day trial of conservative management including NSAIDs, ice application, and continued breastfeeding before initiating antibiotics; for non-lactational mastitis in non-breastfeeding women, start empiric antibiotics immediately targeting Staphylococcus aureus. 1, 2
Lactational Mastitis Management Algorithm
First-Line Conservative Management (Days 1-2)
- Continue breastfeeding or milk expression from the affected breast - this is essential for treatment and stopping will worsen the condition 3, 2, 4
- Administer NSAIDs for pain and inflammation 2
- Apply ice to the affected area 1, 2
- Minimize pumping and avoid overstimulation, as excessive pumping and breast massage can worsen mastitis 2
- Ensure proper infant latch and positioning to prevent recurrence 4, 5
Antibiotic Therapy (If No Improvement After 1-2 Days)
Initiate narrow-spectrum antibiotics targeting Staphylococcus aureus and Streptococcus species: 2, 4
- First-line agents: Dicloxacillin 500 mg every 6 hours OR Cephalexin 1, 4, 5
- Dicloxacillin transfers minimally into breast milk (relative infant dose 0.03%) and is safe for continued breastfeeding 6
- Consider obtaining milk cultures to guide therapy, especially if symptoms worsen or recur 2
- As methicillin-resistant S. aureus becomes more prevalent, antibiotics effective against MRSA may be needed 4
When to Escalate Care
- Hospitalize if: Worsening symptoms despite oral antibiotics, concern for sepsis, or systemic involvement with fever and chills 3, 2
- Intravenous antibiotics are required for severe cases 2
- Continue breastfeeding even during hospitalization; provide breast pump if prolonged separation occurs 3
Non-Lactational Mastitis (Non-Breastfeeding Women)
Immediate Antibiotic Therapy
Do not delay antibiotics in non-breastfeeding women with inflammatory signs - start empiric therapy immediately: 1
- First-line agents: Dicloxacillin OR Cephalexin targeting Staphylococcus aureus 1
- Combine with NSAIDs and ice application 1
- Non-lactational mastitis is more likely infectious from the outset and requires prompt treatment 1
Critical Red Flags - Exclude Inflammatory Breast Cancer
Urgent evaluation is mandatory if any of the following are present: 1
- Erythema occupying ≥1/3 of breast surface 1
- Peau d'orange (orange-peel skin texture) 1
- Symptoms persisting >1 week despite appropriate antibiotics 1
- History of recurrent "mastitis" not responding to antibiotics 1
- Bloody nipple discharge 1
If inflammatory breast cancer is suspected: 1
- Perform urgent ultrasound within 24-48 hours 1
- If mass detected, obtain core needle biopsy within 48 hours 1
- Perform punch biopsy of skin, diagnostic mammogram with ultrasound 1
- Arrange multidisciplinary oncology referral within 24-48 hours 1
- Critical pitfall: A benign skin punch biopsy does not rule out malignancy - comprehensive evaluation is essential 1
Abscess Management
Detection and Treatment
- Approximately 10% of mastitis cases progress to abscess formation 1, 2, 4
- Perform ultrasonography in patients with worsening symptoms, recurrent mastitis, or immunocompromised status 1, 2
- Once abscess forms, surgical drainage or needle aspiration is required 1, 4
- Breastfeeding can continue on the affected side as long as the infant's mouth does not contact purulent drainage 3, 4
Key Clinical Pitfalls to Avoid
- Do not discontinue breastfeeding - this worsens mastitis and increases abscess risk 3, 2
- Avoid excessive pumping, heat application, and aggressive breast massage - these worsen inflammation through overstimulation 2
- Do not delay antibiotics in non-lactational mastitis - it is infectious from onset 1
- Do not assume all breast pain is mastitis - differential includes Mondor disease, costochondritis, chest wall pain, trauma, and inflammatory breast cancer 1
- Do not ignore persistent symptoms >1 week on antibiotics - this may indicate inflammatory breast cancer with significantly worse mortality if diagnosis is delayed 1
Special Considerations
Non-Lactational Mastitis Underlying Pathology
- More commonly occurs in subareolar area or nipple region 1
- Often associated with duct ectasia and periductal inflammation, linked to heavy smoking 1
- In women >50 years, evaluation to exclude malignancy is essential 1
Probiotics
- Use of probiotics for treatment or prevention is not supported by good evidence 2